Catherine Wood's TXG Position Overview
Catherine Wood (via Ark Investment Management LLC) currently holds 12.67 M shares of 10x Genomics, Inc. (TXG) worth $206.6 M, representing 1.37% of the portfolio. First purchased in 2020-Q2, this long-term strategic position has been held for 23 quarters.
Based on 13F filings, Catherine Wood has maintained a strategic position in TXG, demonstrating sustained confidence in this investment. Largest addition occurred in Q2 2024, adding 3.03 M shares. Largest reduction occurred in Q3 2025, reducing 2 M shares.
Analysis based on 13F filings available since 2013 Q2
Catherine Wood's 10x Genomics (TXG) Holding Value Over Time
Track share changes against reported price movement
Quarterly 10x Genomics (TXG) Trades by Catherine Wood
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +779,973 | Add 6.56% | 12.67 M | $16.31 |
| Q3 2025 | -2 M | Reduce 14.43% | 11.89 M | $11.69 |
| Q2 2025 | +1.05 M | Add 8.15% | 13.89 M | $11.58 |
| Q1 2025 | +901,656 | Add 7.55% | 12.85 M | $8.73 |
| Q4 2024 | +1.19 M | Add 11.10% | 11.94 M | $14.36 |
| Q3 2024 | +1.44 M | Add 15.42% | 10.75 M | $22.58 |
| Q2 2024 | +3.03 M | Add 48.22% | 9.31 M | $19.45 |
| Q1 2024 | +2.24 M | Add 55.49% | 6.28 M | $37.53 |
| Q4 2023 | +1.05 M | Add 35.00% | 4.04 M | $55.96 |
| Q3 2023 | -120,089 | Reduce 3.86% | 2.99 M | $41.25 |
| Q2 2023 | -1.04 M | Reduce 25.07% | 3.11 M | $55.84 |
| Q1 2023 | -161,244 | Reduce 3.74% | 4.16 M | $55.79 |
| Q4 2022 | -260,247 | Reduce 5.69% | 4.32 M | $36.44 |
| Q3 2022 | +973,528 | Add 27.02% | 4.58 M | $28.48 |
| Q2 2022 | +211,948 | Add 6.25% | 3.6 M | $51.19 |
| Q1 2022 | +730,472 | Add 27.45% | 3.39 M | $76.07 |
| Q4 2021 | -441,085 | Reduce 14.22% | 2.66 M | $148.96 |
| Q3 2021 | -1.2 M | Reduce 27.86% | 3.1 M | $145.58 |
| Q2 2021 | +795,916 | Add 22.71% | 4.3 M | $195.82 |
| Q1 2021 | +2.97 M | Add 556.82% | 3.5 M | $181.00 |
| Q4 2020 | +302,399 | Add 130.85% | 533,496 | $141.60 |
| Q3 2020 | -105,456 | Reduce 31.33% | 231,097 | $124.68 |
| Q2 2020 | +336,553 | New Buy | 336,553 | $89.31 |
Catherine Wood's 10x Genomics Investment FAQs
Catherine Wood first purchased 10x Genomics, Inc. (TXG) in Q2 2020, acquiring 336,553 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Catherine Wood has held 10x Genomics, Inc. (TXG) for 23 quarters since Q2 2020.
Catherine Wood's largest addition to 10x Genomics, Inc. (TXG) was in Q2 2024, adding 9,313,763 shares worth $181.15 M.
According to the latest 13F filing for Q4 2025, Catherine Wood's firm, Ark Investment Management LLC, owns 12,667,369 shares of 10x Genomics, Inc. (TXG), valued at approximately $206.6 M.
As of the Q4 2025 filing, 10x Genomics, Inc. (TXG) represents approximately 1.37% of Catherine Wood's publicly disclosed stock portfolio, making it one of their key holdings.
Catherine Wood's peak holding in 10x Genomics, Inc. (TXG) was 13,892,103 shares, as reported at the end of Q2 2025.